Literature DB >> 16284526

Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population.

Desiree C Petersen1, Richard H Glashoff, Sadeep Shrestha, Julie Bergeron, Annette Laten, Bert Gold, Estrelita Janse van Rensburg, Michael Dean, Vanessa M Hayes.   

Abstract

CXC chemokine ligand 12 (CXCL12), or stromal cell-derived factor 1 (SDF1), is the only known natural ligand for the HIV-1 coreceptor, CXC chemokine receptor 4 (CXCR4). A single nucleotide polymorphism (SNP) in the CXCL12 gene (SDF1-3'A) has been associated with disease progression to AIDS in some studies, but not others. Mutations in the CXCR4 gene are generally rare and have not been implicated in HIV-1/AIDS pathogenesis. This study analyzed the SDF1-3'A SNP and performed mutation screening for polymorphic markers in the CXCR4 gene to determine the presence or absence of significant associations with susceptibility to HIV-1 infection. The study consisted of 257 HIV-1-seropositive patients and 113 HIV-1-seronegative controls representing a sub-Saharan African population belonging to the Xhosa ethnic group of South Africa. The SDF1-3'A SNP was associated with an increased risk for HIV-1 infection (P = 0.0319) whereas no significant association was observed between the occurrence of the SDF1-3'A SNP and increased or decreased plasma levels of CXCL12. Comprehensive mutation analysis of the CXCR4 gene confirmed a high degree of genetic conservation within the coding region of this ancient population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284526      PMCID: PMC1369993          DOI: 10.1097/01.qai.0000186360.42834.28

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  49 in total

1.  Protective effect of CCR2-64I and not of CCR5-delta32 and SDF1-3'A in pediatric HIV-1 infection.

Authors:  A Mangano; J Kopka; M Batalla; R Bologna; L Sen
Journal:  J Acquir Immune Defic Syndr       Date:  2000-01-01       Impact factor: 3.731

2.  Maternal SDF1 3'A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission.

Authors:  G C John; C Rousseau; T Dong; S Rowland-Jones; R Nduati; D Mbori-Ngacha; T Rostron; J K Kreiss; B A Richardson; J Overbaugh
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Elevated plasma stromal cell-derived factor 1 protein level in the progression of HIV type 1 infection/AIDS.

Authors:  M Ikegawa; J Yuan; K Matsumoto; S Herrmann; A Iwamoto; T Nakamura; S Matsushita; T Kimura; T Honjo; K Tashiro
Journal:  AIDS Res Hum Retroviruses       Date:  2001-05-01       Impact factor: 2.205

4.  Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

Authors:  J P Ioannidis; P S Rosenberg; J J Goedert; L J Ashton; T L Benfield; S P Buchbinder; R A Coutinho; J Eugen-Olsen; T Gallart; T L Katzenstein; L G Kostrikis; H Kuipers; L G Louie; S A Mallal; J B Margolick; O P Martinez; L Meyer; N L Michael; E Operskalski; G Pantaleo; G P Rizzardi; H Schuitemaker; H W Sheppard; G J Stewart; I D Theodorou; H Ullum; E Vicenzi; D Vlahov; D Wilkinson; C Workman; J F Zagury; T R O'Brien
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

5.  Stromal-cell-derived factor 1 prevents the emergence of the syncytium-inducing phenotype of HIV-1 in vivo.

Authors:  A Llano; J Barretina; J Blanco; A Gutiérrez; B Clotet; J A Esté
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

6.  Novel mutations identified using a comprehensive CCR5-denaturing gradient gel electrophoresis assay.

Authors:  D C Petersen; M J Kotze; M D Zeier; A Grimwood; D Pretorius; E Vardas; E J van Rensburg; V M Hayes
Journal:  AIDS       Date:  2001-01-26       Impact factor: 4.177

7.  Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection.

Authors:  A Brambilla; C Villa; G Rizzardi; F Veglia; S Ghezzi; A Lazzarin; M Cusini; S Muratori; E Santagostino; A Gringeri; L G Louie; H W Sheppard; G Poli; N L Michael; G Pantaleo; E Vicenzi
Journal:  J Infect Dis       Date:  2000-07-06       Impact factor: 5.226

8.  Prognostic value of the stromal cell-derived factor 1 3'A mutation in pediatric human immunodeficiency virus type 1 infection.

Authors:  Eleonora Tresoldi; Maria Luisa Romiti; Michele Boniotto; Sergio Crovella; Francesca Salvatori; Elvia Palomba; Angela Pastore; Caterina Cancrini; Maurizio de Martino; Anna Plebani; Guido Castelli; Paolo Rossi; Pier Angelo Tovo; Antonio Amoroso; Gabriella Scarlatti
Journal:  J Infect Dis       Date:  2002-02-14       Impact factor: 5.226

9.  Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)

Authors:  C Winkler; W Modi; M W Smith; G W Nelson; X Wu; M Carrington; M Dean; T Honjo; K Tashiro; D Yabe; S Buchbinder; E Vittinghoff; J J Goedert; T R O'Brien; L P Jacobson; R Detels; S Donfield; A Willoughby; E Gomperts; D Vlahov; J Phair; S J O'Brien
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

10.  Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.

Authors:  B Su; G Sun; D Lu; J Xiao; F Hu; R Chakraborty; R Deka; L Jin
Journal:  Eur J Hum Genet       Date:  2000-12       Impact factor: 4.246

View more
  18 in total

1.  CCR2, CCR5, and CXCL12 variation and HIV/AIDS in Papua New Guinea.

Authors:  Noemi B Hall; Shannon E Bruse; Bangan John; Rajeev K Mehlotra; Melinda J Blood Zikursh; Catherine M Stein; Peter M Siba; Peter A Zimmerman
Journal:  Infect Genet Evol       Date:  2015-09-28       Impact factor: 3.342

2.  Association between SDF1-3'A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases.

Authors:  Ferruh K Işman; Canan Kucukgergin; Selçuk Daşdemir; Bedia Cakmakoglu; Oner Sanli; Sule Seckin
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

3.  Genetic variants of SDF-1 and CXCR4 genes in endometrial carcinoma.

Authors:  Canan Cacina; Sibel Bulgurcuoglu-Kuran; Ahmet Cem Iyibozkurt; Ilhan Yaylim-Eraltan; Bedia Cakmakoglu
Journal:  Mol Biol Rep       Date:  2011-05-24       Impact factor: 2.316

4.  CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.

Authors:  Alda Losi Guembarovski; Roberta Losi Guembarovski; Bruna Karina Banin Hirata; Glauco Akelinghton Freire Vitiello; Karen Mayumi Suzuki; Mayara Tiemi Enokida; Maria Angelica Ehara Watanabe; Edna Maria Vissoci Reiche
Journal:  Mol Biol Rep       Date:  2018-06-20       Impact factor: 2.316

5.  Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.

Authors:  Slavé Petrovski; Jacques Fellay; Kevin V Shianna; Nicole Carpenetti; Johnstone Kumwenda; Gift Kamanga; Deborah D Kamwendo; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Myron S Cohen; David B Goldstein
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

6.  Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.

Authors:  S N Maley; S M Schwartz; L G Johnson; M Malkki; Q Du; J R Daling; S S Li; L P Zhao; E W Petersdorf; M M Madeleine
Journal:  Int J Immunogenet       Date:  2009-09-24       Impact factor: 1.466

7.  CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy.

Authors:  S Matsusaka; S Cao; D L Hanna; Y Sunakawa; M Ueno; N Mizunuma; W Zhang; D Yang; Y Ning; S Stintzing; A Sebio; S Stremitzer; S Yamauchi; A Parekh; S Okazaki; M D Berger; R El-Khoueiry; A Mendez; W Ichikawa; F Loupakis; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2016-08-09       Impact factor: 3.550

Review 8.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

9.  Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia.

Authors:  Sameh Amara; Jorge Domenech; Faouzi Jenhani
Journal:  HIV AIDS (Auckl)       Date:  2010-10-06

10.  The role of genetic variants of Stromal cell-Derived Factor 1 in pediatric HIV-1 infection and disease progression.

Authors:  Ketty Gianesin; Riccardo Freguja; Francesco Carmona; Marisa Zanchetta; Paola Del Bianco; Sandro Malacrida; Marco Montagna; Osvalda Rampon; Carlo Giaquinto; Anita De Rossi
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.